Insider Tour of the UW’s Cancer Vaccine Institute
The UW’s Cancer Vaccine Institute (CVI) is one of the largest labs in the US focused on developing multi-antigenic vaccines and other immune therapies. With a multidisciplinary team of over 30 members, the lab is uniquely focused on early discovery, translational research, and clinical trials — all under one roof.
Come learn about the work of CVI and see where this groundbreaking, potentially life-saving work is happening. Our tour will begin with an introduction by CVI’s director, Dr. Nora Disis. Then small groups will be led on tours of the Institute.
Parking in the South Lake Union garages (enter on Republican Street) is free to UW retirees. Show your retiree Husky Card at the lobby reception desk to have your ticket validated. Click HERE for a map and directions.
Free UW shuttles that start at UWMC – Montlake and at Harborview Medical Center stop at SLU. Metro Transit bus routes 17, 26 and 28 serve the SLU campus.
Accessibility notes: Access to the SLU building from the garage is by elevator and is barrier free. The lab is spacious and accessible. Dr. Disis’s welcome remarks will be amplified. If you have questions about a specific accessibility need, please contact UWRA.
Speakers
Mary (Nora) Disis, MD
Professor, Medicine
Adjunct Professor, Pathology and Obstetrics and Gynecology
Member, Fred Hutchinson Cancer Research Center
Associate Dean, Translational Science, UW School of Medicine
Dr. Disis received her M.D. from the University of Nebraska Medical School and completed a residency and chief residency in Internal Medicine at the University of Illinois in Chicago. Her fellowship in oncology was completed at UW/FHCRC. Dr. Disis is an expert in breast and ovarian cancer immunology and translational research. She is one of the pioneering investigators who discovered that HER-2/neu is a tumor antigen. Her work has led to several clinical trials which evaluate boosting immunity to HER-2/neu with cancer vaccines. Dr. Disis is a member of Alpha Omega Alpha and the American Society of Clinical Investigation. She is the Editor in Chief for JAMA Oncology, and is a member of several committees and task forces for both the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR). She is also the Director of the Institute of Translational Health Sciences and the Director for the Cancer Vaccine Institute at the UW. Her multifaceted research program within the Cancer Vaccine Institute includes the discovery of new antigens for common solid tumors, the development of vaccine and cellular therapy targeting specific antigens, and immunodiagnostics.